|4Feb 9, 4:22 PM ET

DAHL ANDREW A 4

4 · Zivo Bioscience, Inc. · Filed Feb 9, 2018

Insider Transaction Report

Form 4
Period: 2017-11-08
DAHL ANDREW A
President, CEO
Transactions
  • Award

    Common Stock Purchase Warrant

    2017-11-08+10,000,00010,000,000 total
    Exercise: $0.08From: 2017-11-08Exp: 2022-11-08Common Stock (10,000,000 underlying)
Footnotes (1)
  • [F1]The warrants were issued to the reporting person as compensation for his services as President and CEO.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT